NFKB1-targeted metabolites as novel therapeutic approaches for erectile dysfunction: evidence from gut microbiota network pharmacology and machine learning.
Journal:
Sexual medicine
Published Date:
Jun 2, 2025
Abstract
BACKGROUND: Growing evidence suggests that alterations in the gut microbiota may contribute to the pathogenesis of erectile dysfunction (ED).
Authors
Keywords
No keywords available for this article.